Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...
Patent
1978-03-13
1979-04-10
Rosen, Sam
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated via claimed linking group, bond, chelating agent,...
195 17, 195 18, 195 63, A61K 3170, C12B 900, C12L 100
Patent
active
041488881
ABSTRACT:
3-Deazaadenosine has been found to be an effective antiviral and antifocal agent in tissue culture of animals as evidenced by its activity against Rous sarcoma virus, influenza virus, vesicular stomatitis virus, Sindbis virus, and Newcastle disease virus in the range 0.03-0.3 mM. This compound has also shown use as an inhibitor of adenosylhomocysteine hydrolase from beef liver in the range of 0.001-0.008 mM (I.sub.50). The antiviral and antifocal effect is correlated with the inhibition of hydrolysis of adenosylhomocysteine in cells. This inhibition of adenosylhomocysteine hydrolase can also be demonstrated in livers of rats injected with 3-deazaadenosine.
REFERENCES:
chem. Abst. 9th Coll. Index, vol. 76-85, (1972-1976), p. 19488cs.
Cantoni Giulio L.
Chiang Peter K.
Richards Henry H.
Roberts, Jr. John S.
Rosen Sam
The United States of America as represented by the Department of
LandOfFree
3-Deazaadenosine as an inhibitor of adenosylhomocysteine hydrola does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-Deazaadenosine as an inhibitor of adenosylhomocysteine hydrola, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-Deazaadenosine as an inhibitor of adenosylhomocysteine hydrola will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1071384